AGT – Advances in Gene and Cell Therapy [transcript] [audio]
Key Takeaways
- Why It Matters: This discussion provides healthcare professionals with actionable insights relevant to clinical practice and patient care.
- Key Point: Listen to the full episode for detailed discussion and professional insights on this important healthcare topic.
- Key Point: Listen to the full episode for detailed discussion and professional insights on this important healthcare topic.
- Key Point: Listen to the full episode for detailed discussion and professional insights on this important healthcare topic.
- Key Point: Listen to the full episode for detailed discussion and professional insights on this important healthcare topic.
Guest: Jeff Galvin
Presenter: Neal Howard
Guest Bio: Jeff Galvin is CEO of American Gene Technologies International Inc. (AGT), a gene technology company with a broad and robust lentiviral delivery platform.
Segment overview: Mr. Jeff Galvin discusses his vision for the future of healthcare led by advances in gene and cell therapy that parallel the rapid and transformative advances seen in the information technology sector.
Transcript – TBU
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
